Key result
SNPs rs17117817 near OR10P1 and rs2364349 in SNX9 were significantly associated with heart rate response to beta-blockers (Meta-β=5.53 bpm, P=2E-09 and Meta-β=3.5 bpm, P=1E-08, respectively).
Why the study?
Do specific genetic variants predict heart rate response to beta-blockers?
Meta-Analysis (n=1,067)
Do specific genetic variants predict heart rate response to beta-blockers?
Genetic variants in OR10P1 and SNX9 are novel predictors of heart rate response to beta-blockers, highlighting potential pharmacogenomic targets.
Answers are grounded in this paper and cite their sources.
Genetic variants tied to β-blocker HR response; leaves open clinical utility for dosing or outcomes.
Background For many indications, the negative chronotropic effect of β‐blockers is important to their efficacy, yet the heart rate ( HR ) response to β‐blockers varies. Herein, we sought to use a genome‐wide association approach to identify novel single nucleotide polymorphisms ( SNP s) associated with HR response to β‐blockers. Methods and Results We first performed 4 genome‐wide association analyses for HR response to atenolol (a β1‐adrenergic receptor blocker) as: (1) monotherapy or (2) add‐on therapy, in 426 whites and 273 blacks separately from the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) study. A meta‐analysis was then performed between the genome‐wide association analysis performed in PEAR atenolol monotherapy and add‐on therapy, in each race separately, using the inverse variance method assuming fixed effects. From this analysis, SNP s associated with HR response to atenolol at a P <1E‐05 were tested for replication in whites (n=200) and blacks (n=168) treated with metoprolol (a β1‐adrenergic receptor blocker). From the genome‐wide association meta‐analyses, SNP rs17117817 near olfactory receptor family10 subfamily‐p‐member1 ( OR 10P1 ), and SNP rs2364349 in sorting nexin‐9 ( SNX 9 ) replicated in blacks. The combined studies meta‐analysis P values for the rs17117817 and rs2364349 reached genome‐wide significance (rs17117817G‐allele; Meta‐β=5.53 beats per minute, Meta‐ P =2E‐09 and rs2364349 A‐allele; Meta‐β=3.5 beats per minute, Meta‐ P =1E‐08). Additionally, SNP s in the OR 10P1 and SNX 9 gene regions were also associated with HR response in whites. Conclusions This study highlights OR 10P1 and SNX 9 as novel genes associated with changes in HR in response to β‐blockers. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 00246519.
No takes yet. Share an insight, caveat, or question.
Shahin et al. (2018) conducted a meta-analysis in Hypertension (n=1,067). SNPs rs17117817 (OR10P1) and rs2364349 (SNX9) vs. Reference alleles was evaluated on Heart rate response to beta-blockers (Meta-β=5.53 beats per minute, p=2E-09). SNPs rs17117817 near OR10P1 and rs2364349 in SNX9 were significantly associated with heart rate response to beta-blockers (Meta-β=5.53 bpm, P=2E-09 and Meta-β=3.5 bpm, P=1E-08, respectively).
Synapse has enriched 10 related papers. Consider them for comparative context: